Volume 43, Issue 5, Pages (November 2015)

Slides:



Advertisements
Similar presentations
Volume 10, Issue 5, Pages (November 2011)
Advertisements

Volume 5, Issue 1, Pages (January 2009)
Volume 43, Issue 1, Pages (July 2015)
Volume 40, Issue 1, Pages (January 2014)
Chiara Martinoli, Andrea Chiavelli, Maria Rescigno  Immunity 
Volume 31, Issue 1, Pages (July 2009)
Volume 8, Issue 2, Pages (July 2014)
Volume 45, Issue 1, Pages (July 2016)
Volume 28, Issue 2, Pages (February 2008)
Volume 43, Issue 5, Pages (November 2015)
Volume 39, Issue 2, Pages (August 2013)
Volume 25, Issue 11, Pages (November 2017)
Volume 6, Issue 2, Pages (August 2009)
The NLRP12 Inflammasome Recognizes Yersinia pestis
Volume 37, Issue 1, Pages (July 2012)
Volume 35, Issue 6, Pages (December 2011)
Volume 20, Issue 3, Pages (September 2016)
Volume 4, Issue 4, Pages (October 2008)
Influenza Virus-Induced Glucocorticoids Compromise Innate Host Defense against a Secondary Bacterial Infection  Amanda M. Jamieson, Shuang Yu, Charles.
Volume 46, Issue 6, Pages e4 (June 2017)
Volume 42, Issue 4, Pages (April 2015)
Volume 22, Issue 12, Pages (March 2018)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Protective Capacity of Memory CD8+ T Cells Is Dictated by Antigen Exposure History and Nature of the Infection  Jeffrey C. Nolz, John T. Harty  Immunity 
Volume 40, Issue 2, Pages (February 2014)
Volume 29, Issue 6, Pages (December 2008)
Volume 33, Issue 4, Pages (October 2010)
Volume 33, Issue 1, Pages (July 2010)
Volume 7, Issue 1, Pages (January 2010)
Volume 44, Issue 3, Pages (March 2016)
Volume 33, Issue 6, Pages (December 2010)
Volume 27, Issue 4, Pages (October 2007)
Volume 48, Issue 4, Pages e4 (April 2018)
Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock  Dahai Yang, Yuan He, Raul Muñoz-Planillo,
Volume 29, Issue 6, Pages (December 2008)
Volume 40, Issue 1, Pages (January 2014)
Volume 6, Issue 6, Pages (December 2009)
Volume 33, Issue 4, Pages (October 2010)
Volume 33, Issue 4, Pages (October 2010)
Volume 41, Issue 4, Pages (October 2014)
Volume 30, Issue 2, Pages (February 2009)
Volume 14, Issue 2, Pages (August 2013)
Volume 5, Issue 1, Pages (January 2009)
Volume 38, Issue 3, Pages (March 2013)
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 38, Issue 3, Pages (March 2013)
Volume 34, Issue 2, Pages (February 2011)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 44, Issue 5, Pages (May 2016)
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
Volume 24, Issue 1, Pages (January 2016)
Molecular Therapy - Oncolytics
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 26, Issue 4, Pages (April 2007)
Volume 16, Issue 1, Pages (July 2014)
Volume 42, Issue 4, Pages (April 2015)
Volume 40, Issue 4, Pages (April 2014)
Volume 21, Issue 1, Pages (January 2017)
Volume 40, Issue 5, Pages (May 2014)
Volume 38, Issue 6, Pages (June 2013)
Volume 46, Issue 4, Pages (April 2017)
Volume 7, Issue 5, Pages (May 2010)
Volume 41, Issue 4, Pages (October 2014)
Volume 8, Issue 2, Pages (July 2014)
Volume 6, Issue 4, Pages (February 2014)
Volume 25, Issue 1, Pages (July 2006)
Volume 35, Issue 1, Pages (July 2011)
Volume 26, Issue 6, Pages (June 2007)
Volume 21, Issue 1, Pages (January 2017)
Presentation transcript:

Volume 43, Issue 5, Pages 987-997 (November 2015) Inflammasomes Coordinate Pyroptosis and Natural Killer Cell Cytotoxicity to Clear Infection by a Ubiquitous Environmental Bacterium  Vivien I. Maltez, Alan L. Tubbs, Kevin D. Cook, Youssef Aachoui, E. Liana Falcone, Steven M. Holland, Jason K. Whitmire, Edward A. Miao  Immunity  Volume 43, Issue 5, Pages 987-997 (November 2015) DOI: 10.1016/j.immuni.2015.10.010 Copyright © 2015 Elsevier Inc. Terms and Conditions

Immunity 2015 43, 987-997DOI: (10.1016/j.immuni.2015.10.010) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Inflammasomes and the NADPH Oxidase Are Required to Clear Specific CGD Pathogens (A–D) Mice were infected i.p. with (A) 2 × 107 or (B) 1 × 104 CFU of B. thailandensis, (C) 1 × 106 CFU of B. cepcacia, (D) or 1 × 106 CFU of F. philomiragia and monitored for survival. Casp1–/–Casp11–/– mice referred to as Casp1-11DKO. Mice: (A) WT = 9, Casp1-11DKO = 10, Ncf1–/– = 10; (B) WT = 4, Casp1-11DKO = 6, Ncf1–/– = 9; (C) n = 4 for all; (D) n = 5 for all. (E) Mice were infected i.p. with C. violaceum (Cv) at the indicated doses and monitored for survival. Mice: WT = 4, Casp1-11DKO = 7, Ncf1–/– = 4. (F–I) Mice were infected i.p. with 100 CFUs of Cv and bacterial burdens were measured in the liver (F and H) and spleen (G and I) 72 hr later (F and G) or 17 hr later (H and I). (J) Mice were infected i.p. with 100 CFUs of Cv and 72 hr later livers and spleens were embedded in paraffin and H&E stained. Data and statistical analyses are representative of at least two experiments (A–D, H–I), three experiments (F–G), or pooled from two experiments (E). Dashed line indicates limit of detection. ∗p ≤ 0.05; survival curve analysis (A–E), two-tailed unpaired t test (F–I). See also Figure S1. Immunity 2015 43, 987-997DOI: (10.1016/j.immuni.2015.10.010) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 Canonical Inflammasome Signaling via NLRC4 Prevents Lethal Infection by C. violaceum In Vivo (A and B) Mice were infected i.p. with 100 CFUs of Cv and monitored for survival. Nlrc4–/–Asc–/– mice referred to as Nlrc4-AscDKO. Mice: (A) Casp1-11DKO = 4, Nlrc4-AscDKO = 4, Casp11–/– = 5; (B) n = 4 for all. (C–F) Mice were infected i.p. with 100 CFUs of Cv, and bacterial burdens were measured in livers (C and E) and spleens (D and F) 72 hr later. All data and statistical analyses are representative of at least three experiments. ∗p ≤ 0.05; survival curve analysis (A and B); two-tailed unpaired t test (C–F). See also Figure S2. Immunity 2015 43, 987-997DOI: (10.1016/j.immuni.2015.10.010) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 Differential Role for Pyroptosis in the Liver and Spleen (A and B) Mice were infected with 100 CFUs (A) or 104 CFUs (B) Cv and monitored for survival. Il1b–/–Il18–/– mice referred to as Il1b-Il18DKO. Mice: (A) Casp1-11DKO = 5, Il1b-Il18DKO = 7, Il1b–/– = 5; (B) Il1b-Il18DKO = 5, Il1b–/– = 5, Il18–/– = 4, Asc–/– = 5. (C–F) Mice were infected i.p. with 100 CFUs of Cv and bacterial burdens were measured in livers (C and E) and spleens (D and F) 72 hr later. Data and statistical analyses are representative of at least two experiments (A and D–F) or three experiments (B and C) or pooled from two experiments (E and F). ∗p ≤ 0.05; survival curve analysis (A and D), two-tailed unpaired t test (B, C, E, F). Asterisk over a line indicates that all datasets under the line have p ≤ 0.05 for each pair-wise comparison possible. See also Figure S3. Immunity 2015 43, 987-997DOI: (10.1016/j.immuni.2015.10.010) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 Cytotoxic Activity of NK Cells Is Required for Clearance of C. violaceum (A–D, K, and L) Mice were infected i.p. with 104 CFUs (A, B, K, and L) or 100 CFUs (C and D) Cv at the indicated doses and bacterial burdens were measured in livers (A, C, and K) and spleens (B, D, and L) 72 hr later. (A and B) Mice were injected i.p. with 75 μg of isotype or anti-NK1.1 antibody at 1 and 3 days prior to infection. (E) Primary hepatocytes and splenocytes from naive WT mice were treated with LPS, lysed, and examined for caspase-1 via immunoblot. (F) Mice were infected i.p. with 100 CFUs of Cv and bacterial burdens were measured in livers 72 hr later. Equal weight liver sections were removed and the hepatocyte fraction was graphed as a percentage of the total burden by weight. (G) Primary hepatocytes were infected with Cv at an MOI of 25 and percentage of invasive bacteria was determined via gentamycin protection assay. (H) Primary hepatocytes, liver immune cells, and splenocytes were infected with Cv at an MOI of 10 and treated with gentamycin, and LDH release was determined (note, different splenocytes have a distinct LDH content per cell, thus in this case LDH release does not directly translate to percent lysis). (I and J) Mice were infected i.p. with 103 CFUs of L. monocytogenes (Lm) and bacterial burdens were measured in livers (I) and spleens (J) 72 hr later. Data and statistical analyses are representative of two experiments (C, D, I, J) or pooled from two (K, L) or three (A, B) experiments. ∗p ≤ 0.05; two-tailed unpaired t test (A–D and I–L). Error bars in (F)–(H) indicate SEM. See also Figure S4. Immunity 2015 43, 987-997DOI: (10.1016/j.immuni.2015.10.010) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 5 Adaptive Immune Responses Are Not Required for Sterilizing Immunity against C. violaceum Mice were infected i.p. with 103 CFUs of Cv and bacterial burdens were measured in livers (A) and spleens (B) at the indicated times. Data and statistical analyses are representative of two experiments. ∗p ≤ 0.05; two-tailed unpaired t test. Immunity 2015 43, 987-997DOI: (10.1016/j.immuni.2015.10.010) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 6 Exogenous IL-18 Recruits NK Cells and Primes Their Cytotoxic Effects (A–G) Mice were infected i.p. with 100 CFUs of Cv and bacterial burdens were measured in livers (A, F, and G) and spleens (B) 72 hr later. (A, B, and F) Mice were injected i.p. with PBS or recombinant mouse IL-18 (0.2 μg/dose at 0, 24, and 48 hr). (F) Mice were injected i.p. with 75 μg of isotype or anti-NK1.1 antibody at 1 and 3 days prior to infection. (C–E) Liver immune cells were collected and prepared for flow cytometry 1 day after infection (C). Markers for conventional NK (NK1.1hiDX5+), liver-resident NK (NK1.1hiDX5–), and (probably) NKT (NK1.1+DX5–CD3+) cell populations (D) were determined in addition to granzyme B staining (E). (H) Hepatocytes were harvested from Ncf1–/– mice infected with 100 Cv 17 hpi. Liver immune cells were harvested from WT mice infected with 104 Cv under three conditions: isotype antibody treatment, anti-NK1.1 antibody treatment, or IL-18 therapy. Cells were coincubated in a 96-well plate and hepatocyte killing was determined by LDH assay 6 hr later. A model of the experimental setup is provided. Data and statistical analyses are representative of at least two experiments (A–F) or pooled from two experiments (F). ∗p ≤ 0.05; two-tailed unpaired t test (A, B, and D–H). Error bars in (D), (E), and (H) indicate SEM. See also Figure S5. Immunity 2015 43, 987-997DOI: (10.1016/j.immuni.2015.10.010) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 7 L. monocytogenes Burdens Are Reduced upon IL-18 Administration Mice were infected i.p. with 103 CFUs of Lm and injected i.p. with PBS or recombinant mouse IL-18 (24, 48, and 72 hr), and bacterial burdens were measured in WT and Prf1−/− mice (A and B), Ifng−/− mice (C and D), and Rag1−/− mice (E and F) livers (A, C, and E) and spleens (B, D, and F) 4 days later. Data and statistical analyses are pooled from two experiments. ∗p ≤ 0.05; two-tailed unpaired t test. Immunity 2015 43, 987-997DOI: (10.1016/j.immuni.2015.10.010) Copyright © 2015 Elsevier Inc. Terms and Conditions